Why the study?
Do pharmacist-led interventions improve medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia?
Do pharmacist-led interventions improve medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia?
Pharmacist-led interventions, particularly multi-faceted approaches, improve medication adherence in patients with hypertension and hyperlipidemia, though their impact on clinical outcomes is less consistent.
May support pharmacist-led adherence programs in hypertension and hyperlipidemia; leaves open consistent clinical outcome benefits.
Pharmacist-led interventions were associated with improved patients' adherence to their medications but were less likely to be consistently associated with the attainment of clinical outcomes. Face-to-face counseling was the most commonly used intervention; while, the multi-faceted interventions were more likely to be effective in improving the overall outcome measures. The rigorous design of targeted interventions with more frequent follow-ups, careful consideration of the involved medications, and patients' characteristics could increase the effectiveness of these interventions.
No takes yet. Share an insight, caveat, or question.
Elnaem et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: